Examkin

Soru

Zorluk: OrtaGastroenterology and Hepatology

A 42-year-old man is evaluated in the clinic for a two-year history of severe, burning epigastric pain and chronic, high-volume watery diarrhea. He reports having had two episodes of melena over the past year. His current medications include high-dose omeprazole, which provides only transient and partial relief of his symptoms. An esophagogastroduodenoscopy is performed, revealing prominently thickened gastric folds and multiple deep ulcerations extending past the duodenal bulb into the distal duodenum and proximal jejunum. The physician suspects a specific neuroendocrine tumor is responsible for this clinical presentation. Arrange the following diagnostic and management steps in the most appropriate chronological sequence for evaluating and treating this patient's suspected condition.

  1. 1Discontinue proton pump inhibitor therapy
  2. 2Measure fasting serum gastrin concentration alongside gastric pH
  3. 3Perform a secretin stimulation test
  4. 4Perform somatostatin receptor imaging (e.g., DOTATATE PET/CT)

Cevap

The most appropriate chronological sequence is to first discontinue proton pump inhibitor therapy, then measure the fasting serum gastrin concentration, followed by a secretin stimulation test for biochemical confirmation, and finally perform somatostatin receptor imaging for tumor localization.
The diagnosis of Zollinger-Ellison syndrome strictly requires sequential biochemical confirmation before anatomic localization. Proton pump inhibitors cause a reactive hypergastrinemia and must be stopped first. Once discontinued, a fasting serum gastrin paired with a gastric pH less than 2.0 is the initial screening test. If gastrin is elevated but not definitively diagnostic (110-1000 pg/mL), a secretin stimulation test is required to confirm the presence of a gastrinoma. Only after biochemical proof is established should the clinician proceed to somatostatin receptor imaging to localize the tumor for potential surgical cure.

Adım Adım Çözüm

1
Discontinue proton pump inhibitor therapy
Restores baseline gastric acid and gastrin dynamics.
Prevents artifactual hypergastrinemia caused by medication-induced achlorhydria.
2
Measure fasting serum gastrin concentration
Identifies inappropriate gastrin elevation.
Serves as the primary initial screening test for suspected Zollinger-Ellison syndrome.
3
Perform a secretin stimulation test
Differentiates gastrinoma from other causes of hypergastrinemia.
Gastrinoma cells paradoxically release massive amounts of gastrin in response to secretin.
4
Perform somatostatin receptor imaging
Localizes the tumor within the gastrinoma triangle or identifies metastases.
Provides anatomic and functional targeting necessary for definitive surgical resection.

Anahtar Kavram

Algorithm for the diagnosis and management of Zollinger-Ellison syndrome (Gastrinoma).
Bu soruyu puanla

Konular

Gastroenterology and Hepatology

Bu konudan daha fazla soru